Navigation Links
FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
Date:7/21/2011

HORSHAM, Pa., July 21, 2011 /PRNewswire/ -- Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S. Food and Drug Administration (FDA) recommended the approval of REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.  REMICADE® was designated orphan drug status by the FDA on November 12, 2003 for the treatment of pediatric UC, and the supplemental Biologics License Application (sBLA) received priority review following its submission to the FDA in December 2010.  

REMICADE®, an anti-tumor necrosis factor (TNF)-alpha therapy, is currently approved for the treatment of adults with moderately to severely active UC, and adults and children with moderately to severely active Crohn's disease.  In addition, REMICADE® is approved for the treatment of moderately to severely active rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis and chronic, severe plaque psoriasis.  

"We are pleased with the advisory committee's support for the approval of REMICADE® as a treatment for pediatric ulcerative colitis," said Jerome A. Boscia, M.D., Vice President, Head of Immunology Development, Centocor Research & Development division of Johnson & Johnson Pharmaceutical Research & Development, L.L.C.  "We hope the FDA will consider this recommendation and approve REMICADE® for this orphan disease."    

The committee reviewed data from a Phase 3 randomized, multicenter, open-label trial evaluating the efficacy and safety of REMICADE® in the treatment of pediatric patients with moderately t
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
2. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
4. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
7. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
8. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
9. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
10. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
11. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... NEW YORK , July 7, 2015 /PRNewswire/ ... of a new generation of drugs within human ... established a sales company in the ... for Paccal Vet-CA1, its leading companion animal therapeutic. ...      (Photo: http://photos.prnewswire.com/prnh/20150703/228329 ) , ...
(Date:7/7/2015)... , July 7, 2015   Mallinckrodt plc ... results on Tuesday, August 4, 2015. A conference call for ...   The call can be accessed in ... http://www.mallinckrodt.com/investors . , By telephone: For both listen-only participants ... portion of the call, the telephone dial-in number in the ...
(Date:7/7/2015)... 7, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug ... non-binding Letter of Intent (LoI) for an investment and ... Sinopharm Capital Management Co. Ltd. and Hefei Life Science ... Hefei ) potentially valued at $50,000,000 plus ...
Breaking Medicine Technology:Oasmia Pharmaceutical Launches US Brand and Sales Platform 2Mallinckrodt plc To Report Third Quarter Fiscal 2015 Results On August 4, 2015 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 3Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 4Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 5
... (NYSE: BSX ) is scheduled to present at ... Ray Elliott, President and Chief Executive Officer, will ... at approximately 9:30 a.m. PT.  Following the presentation, Jeff Capello, ... Elliott in a question and answer session. A ...
... Calif., Dec. 27, 2010 King Pharmaceuticals®, Inc. ... PTIE ) today announced that King has resubmitted ... U.S. Food and Drug Administration (FDA) in response to a ...  This is a Class 2 resubmission with a six month ...
Cached Medicine Technology:King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 2King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 3
(Date:7/7/2015)... ... July 07, 2015 , ... Bayco’s ... with the introduction of the Nightstick XPP-5422GM , the world’s first Intrinsically ... at its base and one on its clip. The new Nightstick XPP-5422GM is ...
(Date:7/7/2015)... , ... July 07, 2015 ... ... leading provider of unified communication management solutions, has announced the release of ... , This service pack includes a number of enhancements to the already ...
(Date:7/7/2015)... DC (PRWEB) , ... July 07, 2015 , ... ... Officer and well-known patient advocate, will be recognized by the White House as ... Part of the newly-launched President’s Precision Medicine Initiative, the Champions of Change program ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... the pre-clinical stages of drug discovery. iPSCs are generated from adult cells, such ... into any cell type in the human body. , iPSC-derived cardiomyocytes ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... areas of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine ( ... Meeting, July 9-12 in Orlando, FL. As a leader in orthopaedic sports ...
Breaking Medicine News(10 mins):Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 2Health News:Dual Magnets Add Convenience to Safety in New Nightstick® XPP-5422GM Intrinsically Safe Dual-LightTM Flashlight 3Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6
... , SAN DIEGO, Nov. 9 , , WHAT: All PETCO stores ... workshop facilitated by specially trained in-store nutrition, ... workshop, pet parents will learn about the nutritional needs of, ... to discuss the benefits of, good ...
... , This release is available in French . ... in twos: male and female. In human bodies trillions of cells ... are composed. Yet these don,t come in twos, they are ... backbone of life and illness scientists have long searched ...
... disease, often leading to disability or an increased risk ... Studies led by Deborah Young-Corbett, a faculty member in ... types of sanding tools are highly effective in reducing ... industry,s usage of the available technology remains very low. ...
... to read Charles Darwin,s "Origin of Species," whose publication celebrates its ... others who would like to know what the book is about, ... World-renowned evolutionary biologist David Reznick is the author of ... to the Origin of Species " (Princeton University Press, ...
... of seasonal flu could be severe in this group of ... Pregnant women who are depressed may suffer severe symptoms if ... State University researchers assessed depressive symptoms and took blood samples ... shot. Those with significant symptoms of depression had a stronger ...
... Industry leader ... 7 and Windows Server 2008 R2; aligns customer migration plans with solution readiness. , ... Scottsdale, AZ (PRWEB) Nov. 9, 2009 -- , , ... ready their IT environments for the migration to Windows 7 and Windows 2008 Server R2, ...
Cached Medicine News:Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:Book by UC Riverside biologist explains Darwin's 'Origin of Species' 2Health News:Depressed and Pregnant? Flu Shot May Be Needed 2Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 2Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 3Health News:Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: